Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ardent Health (ARDT) Other Accumulated Expenses (2023 - 2025)

Historic Other Accumulated Expenses for Ardent Health (ARDT) over the last 3 years, with Q3 2025 value amounting to $266.4 million.

  • Ardent Health's Other Accumulated Expenses rose 613.96% to $266.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $266.4 million, marking a year-over-year increase of 613.96%. This contributed to the annual value of $239.8 million for FY2024, which is 280.92% up from last year.
  • As of Q3 2025, Ardent Health's Other Accumulated Expenses stood at $266.4 million, which was up 613.96% from $237.9 million recorded in Q2 2025.
  • In the past 5 years, Ardent Health's Other Accumulated Expenses registered a high of $278.4 million during Q2 2024, and its lowest value of $226.3 million during Q1 2025.
  • Its 3-year average for Other Accumulated Expenses is $247.6 million, with a median of $239.8 million in 2024.
  • Data for Ardent Health's Other Accumulated Expenses shows a peak YoY increase of 613.96% (in 2025) and a maximum YoY decrease of 1452.99% (in 2025) over the last 5 years.
  • Ardent Health's Other Accumulated Expenses (Quarter) stood at $233.3 million in 2023, then rose by 2.81% to $239.8 million in 2024, then grew by 11.06% to $266.4 million in 2025.
  • Its Other Accumulated Expenses was $266.4 million in Q3 2025, compared to $237.9 million in Q2 2025 and $226.3 million in Q1 2025.